(Q37763624)

22 August 2017

title

Intrathecal methotrexate treatment in multiple sclerosis (English)

1 reference

22 August 2017

0 references

1 reference

Saud A Sadiq

1

1 reference

22 August 2017

Elena V Simon

series ordinal

2

1 reference

22 August 2017

Lauren M Puccio

series ordinal

3

1 reference

22 August 2017

publication date

10 June 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

257

1 reference

22 August 2017

issue

11

1 reference

22 August 2017

page(s)

1806-1811

1 reference

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

22 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00415-010-5614-4

Alemtuzumab vs. interferon beta-1a in early multiple sclerosis

21 January 2018

1 reference

12 December 2020

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

1 reference

12 December 2020

Historical perspective on the use of methotrexate for the treatment of rheumatoid arthritis

1 reference

12 December 2020

Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries

1 reference

12 December 2020

Survival, and time to an advanced disease state or progression, of untreated patients with moderately severe multiple sclerosis in a multicenter observational database: relevance for design of a clinical trial for high dose immunosuppressive therapy

1 reference

12 December 2020

The glial scar and central nervous system repair

1 reference

12 December 2020

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Bleak prospects for primary progressive multiple sclerosis therapy: downs and downs, but a glimmer of hope

1 reference

12 December 2020

Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis

1 reference

12 December 2020

Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis

1 reference

12 December 2020

Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results

1 reference

12 December 2020

Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis.

1 reference

12 December 2020

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

1 reference

12 December 2020

B cells and multiple sclerosis

1 reference

12 December 2020

The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy

1 reference

12 December 2020

A placebo-controlled, double-blind, randomized, two-center, pilot trial of Cop 1 in chronic progressive multiple sclerosis

1 reference

12 December 2020

Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study

1 reference

12 December 2020

Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials

1 reference

12 December 2020

Chronic myeloid leukemia associated with mitoxantrone treatment in a patient with MS.

1 reference

12 December 2020

10.1007/S00415-010-5614-4

Identifiers

DOI

1 reference

22 August 2017

1 reference